159 related articles for article (PubMed ID: 18478504)
1. [kappa-light chain amyloidosis of the liver, a rare cause of liver enzyme elevation].
Borde JP; Link R; Offensperger WB
Dtsch Med Wochenschr; 2008 May; 133(21):1116-20. PubMed ID: 18478504
[TBL] [Abstract][Full Text] [Related]
2. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
3. Head and neck amyloidosis: clinicopathological features and immunohistochemical analysis of 14 cases.
Gouvêa AF; Ribeiro AC; León JE; Carlos R; de Almeida OP; Lopes MA
J Oral Pathol Med; 2012 Feb; 41(2):178-85. PubMed ID: 21883489
[TBL] [Abstract][Full Text] [Related]
4. Diffuse parenchymal amyloidosis of lungs and breast. Its association with diffuse plasmacytosis and kappa-chain gammopathy.
Hardy TJ; Myerowitz RL; Bender BL
Arch Pathol Lab Med; 1979 Oct; 103(11):583-5. PubMed ID: 114145
[TBL] [Abstract][Full Text] [Related]
5. AL-amyloidosis is underdiagnosed in renal biopsies.
Novak L; Cook WJ; Herrera GA; Sanders PW
Nephrol Dial Transplant; 2004 Dec; 19(12):3050-3. PubMed ID: 15507480
[TBL] [Abstract][Full Text] [Related]
6. Progressive renal light chain amyloidosis with the absence of detectable free monoclonal light chains after an autologous hematopoietic stem cell transplant for amyloid light chain amyloidosis.
Roth RM; Benson D; Hebert LA; Bissell MG; Satoskar AA; Nadasdy T; Brodsky SV
Arch Pathol Lab Med; 2013 Sep; 137(9):1304-8. PubMed ID: 23991744
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic approach to and follow-up of difficult cases of AL amyloidosis.
Perfetti V; Garini P; Vignarelli MC; Marinone MG; Zorzoli I; Merlini G
Haematologica; 1995; 80(5):409-15. PubMed ID: 8566880
[TBL] [Abstract][Full Text] [Related]
8. Quantitative serum free light chain assay in the diagnostic evaluation of AL amyloidosis.
Akar H; Seldin DC; Magnani B; O'Hara C; Berk JL; Schoonmaker C; Cabral H; Dember LM; Sanchorawala V; Connors LH; Falk RH; Skinner M
Amyloid; 2005 Dec; 12(4):210-5. PubMed ID: 16399645
[TBL] [Abstract][Full Text] [Related]
9. Heavy-chain amyloidosis in TGFBI-negative and gelsolin-negative atypical lattice corneal dystrophy.
Pradhan MA; Henderson RA; Patel D; McGhee CN; Vincent AL
Cornea; 2011 Oct; 30(10):1163-6. PubMed ID: 21743312
[TBL] [Abstract][Full Text] [Related]
10. A case of primary immunoglobulin light chain amyloidosis with a delayed appearance of Bence Jones protein in urine.
Kurusu A; Yamada T; Yamaji K; Nishitani M; Tashiro K; Maeda K; Horikoshi S; Shirato I; Rinno H; Tomino Y
Nephrology (Carlton); 2004 Jun; 9(3):122-5. PubMed ID: 15189172
[TBL] [Abstract][Full Text] [Related]
11. Clinical usefulness of free light chain concentration as a tumor marker in multiple myeloma.
Kang SY; Suh JT; Lee HJ; Yoon HJ; Lee WI
Ann Hematol; 2005 Sep; 84(9):588-93. PubMed ID: 15883850
[TBL] [Abstract][Full Text] [Related]
12. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
13. [Amyloidosis of the A-kappa type].
Scherwitz C; Linke RP; Schmitt FJ
Hautarzt; 1986 Jun; 37(6):343-6. PubMed ID: 3087912
[TBL] [Abstract][Full Text] [Related]
14. Immunogold quantitation of immunoglobulin light chains in renal amyloidosis and kappa light chain nephropathy.
Silver MM; Hearn SA; Walton JC; Lines LA; Walley VM
Am J Pathol; 1990 May; 136(5):997-1007. PubMed ID: 1693473
[TBL] [Abstract][Full Text] [Related]
15. Renal granular monoclonal light chain deposits: morphological aspects in 11 cases.
Noel LH; Droz D; Ganeval D; Grunfeld JP
Clin Nephrol; 1984 May; 21(5):263-9. PubMed ID: 6428790
[TBL] [Abstract][Full Text] [Related]
16. Systemic immunoglobulin light-chain amyloidosis.
Comenzo RL
Clin Lymphoma Myeloma; 2006 Nov; 7(3):182-5. PubMed ID: 17229332
[TBL] [Abstract][Full Text] [Related]
17. Development of rapidly progressive liver light chain deposition under VAD chemotherapy in multiple myeloma.
Samanez C; Domingo A; Cibeira MT; Miquel R; Soler M; Bladé J
Eur J Haematol; 2006 Jan; 76(1):83-5. PubMed ID: 16343276
[TBL] [Abstract][Full Text] [Related]
18. Immunocytochemical detection of kappa and lambda light chain V region subgroups in human B-cell malignancies.
Solomon A; Weiss DT; Macy SD; Antonucci RA
Am J Pathol; 1990 Oct; 137(4):855-62. PubMed ID: 2121042
[TBL] [Abstract][Full Text] [Related]
19. [Histological and immunohistochemical examinations in the diagnosis of hepatic amyloidosis].
Mikhaleva LM; Gioeva ZV; Rёken K
Arkh Patol; 2015; 77(4):11-16. PubMed ID: 26485775
[TBL] [Abstract][Full Text] [Related]
20. Immunoglobulin light and heavy chain amyloidosis AL/AH: renal pathology and differential diagnosis.
Picken MM
Contrib Nephrol; 2007; 153():135-55. PubMed ID: 17075228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]